Findings

What do systematic reviews say?

4 questions · 4 findings · 2 reviews · Wounds

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 4 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Intervention not reported

One day of piperacillin, cefazolin, cefmetazole, or cefotiam versus three days of piperacillin, cefazolin, cefmetazole, or cefotiam (elective colorectal surgery) · surgical patients

It is very uncertain whether the intervention changes one day of piperacillin, cefazolin, cefmetazole, or cefotiam versus… (very low certainty).

1 finding from 1 review

Antibiotic prophylaxis for the prevention of methicillin‐resistant Staphylococcus aureus (MRSA) related complications… 2013 · Cochrane Headline outcomes only
RR 1.06 [0.52, 2.15]
1 study · 521 participants
Very low

Intervention not reported

One day of piperacillin, cefazolin, cefmetazole, or cefotiam versus three days of piperacillin, cefazolin, cefmetazole, or cefotiam (elective colorectal surgery) · surgical patients

1 finding from 1 review

Antibiotic prophylaxis for the prevention of methicillin‐resistant Staphylococcus aureus (MRSA) related complications… 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 521 participants
Very low

Intervention not reported

Ertapenem versus piperacillin/tazobactam · patients with MRSA‐infected non surgical wounds

It is very uncertain whether the intervention changes ertapenem versus piperacillin/tazobactam (very low certainty).

1 finding from 1 review

Antibiotic therapy for the treatment of methicillin‐resistant Staphylococcus aureus (MRSA) in non surgical wounds 2013 · Cochrane Headline outcomes only
RR 0.71 [0.06, 9.1]
1 study · 10 participants
Very low

Intervention not reported

Moxifloxacin versus piperacillin/tazobactam followed by amoxycillin/clavulanate · patients with MRSA‐infected non surgical wounds

It is very uncertain whether the intervention changes moxifloxacin versus piperacillin/tazobactam followed by… (very low certainty).

1 finding from 1 review

Antibiotic therapy for the treatment of methicillin‐resistant Staphylococcus aureus (MRSA) in non surgical wounds 2013 · Cochrane Headline outcomes only
RR 0.87 [0.56, 1.36]
1 study · 23 participants
Very low